Johnathon Schaech

Johnathon Schaech

Ask VT AI

View News Summary

Eli Lilly to acquire Adverum Biotechnologies in a deal worth up to $12.47 per share, with a focus on Adverum's gene therapy candidate Ixo-vec.
Shield AI unveils conceptual X-BAT autonomous VTOL with advanced capabilities and combat-proven heritage.
Trump declines Zelensky's request for Tomahawk missiles after call with Putin, citing escalation risks and U.S. defense needs.

20 days

United States Politics

Discover the latest news, candidates,  and key topics of US politics

Ask VT AI

View News Summary

Eli Lilly to acquire Adverum Biotechnologies in a deal worth up to $12.47 per share, with a focus on Adverum's gene therapy candidate Ixo-vec.
Shield AI unveils conceptual X-BAT autonomous VTOL with advanced capabilities and combat-proven heritage.
Trump declines Zelensky's request for Tomahawk missiles after call with Putin, citing escalation risks and U.S. defense needs.

20 days

United States Politics

Discover the latest news, candidates,  and key topics of US politics

Most Reported By
News from Johnathon Schaech